P/E at 61.88 vs Industry's 61.10: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: A Slight Premium in a High-P/E Industry

The hospital sector is characterised by elevated valuations, with the industry P/E standing at 61.10. Apollo Hospitals Enterprise Ltd. trades at a P/E of 61.88, reflecting a premium of approximately 1.3% over the sector average. This premium is relatively modest, suggesting that the market’s pricing of the company aligns closely with sector norms rather than signalling an extreme valuation divergence. The premium may be indicative of the company’s market leadership and consistent earnings growth, but it also implies limited margin for valuation expansion relative to peers. Apollo Hospitals Enterprise Ltd.’s valuation thus warrants scrutiny in the context of its recent performance and technical positioning — previously rated Hold, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Strong Long-Term Gains with Consistent Outperformance

Examining returns over multiple horizons reveals a robust performance by Apollo Hospitals Enterprise Ltd.. The one-year return stands at 17.73%, significantly outperforming the Sensex’s negative 7.08% over the same period. This outperformance extends to shorter and longer timeframes: the three-month return is a positive 7.55% versus the Sensex’s -7.16%, while the year-to-date gain is 18.79% compared to the Sensex’s -10.40%. Over three, five, and ten years, the stock has delivered compounded returns of 81.46%, 162.63%, and an impressive 523.05%, respectively, dwarfing the Sensex’s corresponding returns of 22.17%, 49.67%, and 189.60%. This consistent alpha generation underscores the company’s resilience and growth trajectory within the hospital sector.

However, the stock’s recent trading session saw a slight decline of 0.47%, underperforming the sector by 0.41%. This followed a five-day consecutive gain streak, suggesting a potential pause or minor correction in momentum. The stock is currently trading just 1.43% below its 52-week high of Rs 8,490.3, indicating proximity to peak levels but also hinting at possible resistance near these prices — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Moving Average Configuration: Bullish Across All Key Averages

The technical setup for Apollo Hospitals Enterprise Ltd. is notably strong, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment suggests a sustained upward trend across both short and long-term horizons. The stock’s position above the 200-day moving average is particularly significant, as it often signals a bullish medium-to-long-term outlook. The recent pullback after five consecutive days of gains may represent a healthy consolidation rather than a reversal, but the overall moving average configuration supports the continuation of the prevailing uptrend. Is this momentum sustainable or nearing exhaustion?

Sector Performance Context: Hospital Sector Showing Mixed but Mostly Positive Results

The hospital sector, within which Apollo Hospitals Enterprise Ltd. operates, has delivered a mixed performance recently. While some stocks in the sector have experienced flat or negative returns, the majority have posted positive gains, reflecting ongoing demand for healthcare services and sectoral resilience. The sector’s average P/E of 61.10 is elevated, consistent with the premium valuations often accorded to healthcare companies due to their growth prospects and defensive characteristics. This environment provides a backdrop against which Apollo Hospitals Enterprise Ltd.’s valuation and performance can be assessed, highlighting its relative strength within a competitive landscape.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd.. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technical indicators. While the current rating is not disclosed, the data-driven approach considers the company’s consistent outperformance, premium valuation, and strong technical positioning. This reassessment invites investors to revisit their stance on the stock — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: Data Reflects a Premium Valuation Backed by Strong Performance and Technical Strength

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its sector’s already elevated valuation. Its consistent outperformance across all measured timeframes, from one day to ten years, underscores its market leadership and growth credentials. The technical indicators reinforce this positive momentum, with the stock positioned above all major moving averages. The recent rating reassessment, following a previous Hold, reflects these factors without revealing the current stance, leaving investors to weigh the valuation premium against the company’s strong fundamentals and sector context — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →